These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
799 related articles for article (PubMed ID: 8221449)
21. Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 4, 6 and 12-14 months of age. Diaz-Mitoma F; Halperin SA; Tapiero B; Hoffenbach A; Zappacosta PS; Radley D; Bradshaw S; Martin JC; Boslego JW; Hesley TM; Bhuyan PK; Silber JL Vaccine; 2011 Feb; 29(6):1324-31. PubMed ID: 21134456 [TBL] [Abstract][Full Text] [Related]
22. Antibody persistence, PRP-specific immune memory, and booster responses in infants immunised with a combination DTPa-HBV-IPV/Hib vaccine. Nolan T; Altmann A; Skeljo M; Streeton C; Schuerman L Vaccine; 2004 Nov; 23(1):14-20. PubMed ID: 15519702 [TBL] [Abstract][Full Text] [Related]
23. Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study. Halperin SA; McDonald J; Samson L; Danzig L; Santos G; Izu A; Smith B; MacDonald N Clin Invest Med; 2002 Dec; 25(6):243-51. PubMed ID: 12516995 [TBL] [Abstract][Full Text] [Related]
24. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine. Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L; Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171 [TBL] [Abstract][Full Text] [Related]
25. Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered. Daum RS; Zenko CE; Given GZ; Ballanco GA; Parikh H; Germino K J Infect Dis; 2001 Nov; 184(10):1293-9. PubMed ID: 11679918 [TBL] [Abstract][Full Text] [Related]
26. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age. Nolan T; Bernstein H; Blatter MM; Bromberg K; Guerra F; Kennedy W; Pichichero M; Senders SD; Trofa A; Collard A; Sullivan DC; Descamps D Pediatrics; 2006 Sep; 118(3):e602-9. PubMed ID: 16950952 [TBL] [Abstract][Full Text] [Related]
27. Development of a guinea-pig model for potency/immunogenicity evaluation of diphtheria, tetanus acellular pertussis (DTaP) and Haemophilus influenzae type b polysaccharide conjugate vaccines. Gupta RK; Anderson R; Cecchini D; Rost B; Griffin P; Benscoter K; Xu J; Montanez-Ortiz L; Siber GR Dev Biol Stand; 1996; 86():283-96. PubMed ID: 8785957 [TBL] [Abstract][Full Text] [Related]
28. Interchangeability of Haemophilus influenzae type b vaccines in the primary series: evaluation of a two-dose mixed regimen. Bewley KM; Schwab JG; Ballanco GA; Daum RS Pediatrics; 1996 Nov; 98(5):898-904. PubMed ID: 8909483 [TBL] [Abstract][Full Text] [Related]
29. Role of whole-cell pertussis vaccine in severe local reactions to the preschool (fifth) dose of diphtheria-pertussis-tetanus vaccine. Scheifele DW; Bjornson G; Halperin SH; Mitchell L; Boraston S CMAJ; 1994 Jan; 150(1):29-35. PubMed ID: 8275406 [TBL] [Abstract][Full Text] [Related]
30. Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four and six months of age. Avendano A; Ferreccio C; Lagos R; Horwitz I; Cayazzo M; Fritzell B; Meschievitz C; Levine M Pediatr Infect Dis J; 1993 Aug; 12(8):638-43. PubMed ID: 8414775 [TBL] [Abstract][Full Text] [Related]
31. A fully liquid diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis--Haemophilus influenzae type b conjugate vaccine: immunogenicity and safety of primary vaccination in Taiwanese infants. Lin TY; Wang YH; Chang LY; Huang YC; Kao HT; Lin PY; Lu HK; Chavand P; Ortiz E Int J Infect Dis; 2007 Mar; 11(2):129-36. PubMed ID: 16762579 [TBL] [Abstract][Full Text] [Related]
32. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants. Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224 [TBL] [Abstract][Full Text] [Related]
33. Four is better than nine. a combined diphtheria-tetanus-pertussis-hepatitis B-Haemophilus influenzae type b vaccine for routine immunization in Malaysia. Wong SL; Soosai P; Teoh YL; Han HH; Lefevre I; Bock HL Southeast Asian J Trop Med Public Health; 2008 May; 39(3):474-83. PubMed ID: 18564687 [TBL] [Abstract][Full Text] [Related]
34. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine. Pichichero ME; Bernstein H; Blatter MM; Schuerman L; Cheuvart B; Holmes SJ; J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189 [TBL] [Abstract][Full Text] [Related]
35. Effectiveness and safety of an Haemophilus influenzae type b conjugate vaccine (PRP-T) in young infants. Kaiser-UCLA Vaccine Study Group. Vadheim CM; Greenberg DP; Partridge S; Jing J; Ward JI Pediatrics; 1993 Aug; 92(2):272-9. PubMed ID: 8337029 [TBL] [Abstract][Full Text] [Related]
36. The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination. Goldblatt D; Richmond P; Millard E; Thornton C; Miller E J Infect Dis; 1999 Aug; 180(2):538-41. PubMed ID: 10395878 [TBL] [Abstract][Full Text] [Related]
37. Immunogenicity and safety of Haemophilus influenzae type b conjugate vaccine (HibTITER) and a combination vaccine of diphtheria, tetanus, pertussis and HibTITER (TETRAMUNE) in two-month-old infants. Huang LM; Chang PF; Lee PI; Chiu HH; Tsai SY; Lee CY J Microbiol Immunol Infect; 1998 Sep; 31(3):180-6. PubMed ID: 10496155 [TBL] [Abstract][Full Text] [Related]
38. Safety and immunogenicity of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-pertussis (DTP) combination vaccine administered in a dual-chamber syringe to infants in Belgium and Chile. Hoppenbrouwers K; Lagos R; Swennen B; Ethevenaux C; Knops J; Levine MM; Desmyter J Vaccine; 1998; 16(9-10):921-7. PubMed ID: 9682338 [TBL] [Abstract][Full Text] [Related]
39. The effect of reconstitution of an Haemophilus influenzae type b-tentanus toxoid conjugate (PRP-T) vaccine on the immune responses to a diphtheria-tetanus-whole cell pertussis (DTwP) vaccine: a five-year follow-up. Hoppenbrouwers K; Roelants M; Ethevenaux C; Vandermeulen C; Knops J; Desmyter J Vaccine; 1999 Jun; 17(20-21):2588-98. PubMed ID: 10418907 [TBL] [Abstract][Full Text] [Related]
40. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants. Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]